BioAffinity Gross Profit from 2010 to 2025
BIAF Stock | USD 0.77 0.01 1.28% |
Check BioAffinity Technologies, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioAffinity Technologies,'s main balance sheet or income statement drivers, such as , as well as many indicators such as . BioAffinity financial statements analysis is a perfect complement when working with BioAffinity Technologies, Valuation or Volatility modules.
BioAffinity |
About BioAffinity Technologies, Financial Statements
BioAffinity Technologies, stakeholders use historical fundamental indicators, such as BioAffinity Technologies,'s Gross Profit, to determine how well the company is positioned to perform in the future. Although BioAffinity Technologies, investors may analyze each financial statement separately, they are all interrelated. For example, changes in BioAffinity Technologies,'s assets and liabilities are reflected in the revenues and expenses on BioAffinity Technologies,'s income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in bioAffinity Technologies,. Please read more on our technical analysis and fundamental analysis pages.
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company was founded in 2014 and is based in San Antonio, Texas. Bioaffinity Technologies operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.
Currently Active Assets on Macroaxis
EBR | Centrais Electricas Brasileiras | |
HE | Hawaiian Electric Industries | |
VFC | VF Corporation | |
BVHMF | Vistry Group PLC | |
S | SentinelOne |
Check out the analysis of BioAffinity Technologies, Correlation against competitors. For more detail on how to invest in BioAffinity Stock please use our How to Invest in BioAffinity Technologies, guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Business Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioAffinity Technologies,. If investors know BioAffinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioAffinity Technologies, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of bioAffinity Technologies, is measured differently than its book value, which is the value of BioAffinity that is recorded on the company's balance sheet. Investors also form their own opinion of BioAffinity Technologies,'s value that differs from its market value or its book value, called intrinsic value, which is BioAffinity Technologies,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioAffinity Technologies,'s market value can be influenced by many factors that don't directly affect BioAffinity Technologies,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioAffinity Technologies,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if BioAffinity Technologies, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioAffinity Technologies,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.